Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
Retail	12.95B	13.37B	12.63B	13.58B	12.35B
Retail Growth	-3.13%	5.90%	-7.00%	9.94%	5.15%
Wholesale	3.78B	4.09B	3.90B	3.32B	1.92B
Wholesale Growth	-7.50%	4.81%	17.51%	72.52%	193.68%
Unallocated Other Operating Income	599.91M	538.72M	503.73M	307.42M	312.21M
Unallocated Other Operating Income Growth	11.36%	6.95%	63.86%	-1.54%	22.43%
Convenience Product Sales	-	-	347.26M	226.06M	-
Convenience Product Sales Growth	-	-	53.61%	-	-
Total	17.34B	18.00B	17.38B	17.43B	14.59B
Total Growth	-3.69%	3.57%	-0.29%	19.50%	15.26%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016
South-West	13.45B	14.33B	14.39B	14.74B	12.33B
South-West Growth	-6.11%	-0.46%	-2.34%	19.56%	16.90%
South China Region	1.74B	1.73B	1.54B	1.50B	1.26B
South China Region Growth	0.34%	12.30%	2.78%	18.82%	2.05%
Northern China	936.23M	943.76M	822.81M	804.46M	624.07M
Northern China Growth	-0.80%	14.70%	2.28%	28.91%	11.34%
East China	158.96M	153.95M	55.20M	10.15M	8.60M
East China Growth	3.26%	178.90%	443.77%	17.97%	-7.36%
Central China	450.93M	303.94M	62.21M	60.01M	43.33M
Central China Growth	48.36%	388.61%	3.66%	38.48%	49.76%
Unallocated	599.91M	538.72M	503.73M	307.42M	312.21M
Unallocated Growth	11.36%	6.95%	63.86%	-1.54%	22.43%
Overseas Region	-	-	-	9.72M	8.36M
Overseas Region Growth	-	-	-	16.33%	-56.61%
Total	17.34B	18.00B	17.38B	17.43B	14.59B
Total Growth	-3.69%	3.57%	-0.29%	19.50%	15.26%

Source: S&P Global Market Intelligence.